Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology. The Company uses its cell penetrating peptide platform to develop and progress therapeutic vaccines in oncology, including cancer vaccines, immunotherapy, and therapeutic cancer vaccines.
|BioMedPartners, Boehringer Ingelheim Venture Fund, Helsinn Investment Fund, Schroder Adveq, High-Tech Gründerfonds, VI Partners AG, Diego Braguglia, Riccardo Braglia, Frank Kalkbrenner, Andreas Wallnöfer|
Who are Amal Therapeutics key executives?
Amal Therapeutics's key executives are Laurence de Schoulepnikoff, Madiha Derouazi and Greg Elson.
How many employees does Amal Therapeutics have?
Amal Therapeutics has 22 employees.
Who are Amal Therapeutics competitors?
Competitors of Amal Therapeutics include Eutilex, Foghorn Therapeutics and Reflexion Medical.
Where is Amal Therapeutics headquarters?
Amal Therapeutics headquarters is located at La Tulipe 64 Avenue de la Roseraie, Genève.
Where are Amal Therapeutics offices?
Amal Therapeutics has an office in Genève.
How many offices does Amal Therapeutics have?
Amal Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies